Welcome to The Breast Cancer Network News

The BCN News provides its 20,000 readers with breaking news on breast cancer treatment and research daily. Along with thousands of breast cancer patients and survivors, The BCN News is read in nearly every major cancer and health organization, all the major breast cancer organizations, and major research laboratories and universities around the world.

For a free trial subscription to The BCN News, sign up here, or use the following Constant Contact subscribe option:

Join Our Mailing List
Email:


Today's News Sponsors

Triple Breast Cancer Foundation Night 4 Pink Young Women and Breast Cancer: The Empowerment Series Save the Girls Tour of Long Beach Island
The Triple Negative Breast Cancer Foundation
Our Inspiration

Understanding Triple Negative Breast Cancer These subtypes of breast cancer are generally diagnosed based upon the presence, or lack of, three "receptors" known to fuel most breast cancers: estrogen receptors, progesterone receptors and human epidermal growth factor receptor 2 (HER2). The most successful treatments for breast cancer target these receptors.

Unfortunately, none of these receptors are found in women with triple negative breast cancer. In other words, a triple negative breast cancer diagnosis means that the offending tumor is estrogen receptor-negative, progesterone receptor-negative and HER2-negative, thus giving rise to the name "triple negative breast cancer." On a positive note, this type of breast cancer is typically responsive to chemotherapy. However, triple negative tumors generally do not respond to receptor targeted treatments, and they can be particularly aggressive, and more likely to recur.

The Triple Negative Breast Cancer Foundation is devoted to finding targeted treatment for triple negative breast cancer. With your help, we will find a cure.

Download a PDF of the Guide to Understanding Triple Negative Breast Cancer, developed in collaboration with Living Beyond Breast Cancer.

For more information on Triple Negative Breast Cancer, our Foundation, or how you can help find a cure, visit: TNBCFoundation.org



BCN News Articles for: November 22, 2014

  • More breast cancer patients opting for mastectomy, Vanderbilt study finds
  • Nationwide Trends in Mastectomy for Early-Stage Breast Cancer
  • Common blood pressure medication does not increase risk of breast cancer, new study finds
  • How do I tell the children? Women's experiences of sharing information about breast cancer diagnosis and treatment
  • The sodium channel 1 subunit mediates outgrowth of neurite-like processes on breast cancer cells and promotes tumour growth and metastasis
  • Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer
  • Adherence to cancer prevention guidelines and risk of breast cancer
  • Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients
  • Implementing and evaluating shared decision making in oncology practice
  • Patients Prefer Chemotherapy on the Same Day As Their Medical Oncology Outpatient Appointment
  • Metabolic `reprogramming' by the p53 gene family leads to tumor regression
  • IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo


Current BCN News subscribers can access the full site, including all of today's articles as well as three years of breast cancer news, by entering their email address below:

Email:
Not a subscriber yet? Sign up now for a free 2-week trial subscription, which includes full site access.

The BCN News: The Cancer News You Need To Know